CUSIP 09073M104 · who reports it, how much, and how much it matters to them
52 of the 720 hedge fund managers we track reported shares of BIO-TECHNE Corp (Nasdaq: TECH) on Form 13F for 30 June 2026. Between them they reported USD 1.5bn. The largest position belongs to HBK Investments, at USD 482m. The manager with the most riding on it is Versor Investments, where it is 6.3% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | HBK Investments7 funds on PPLI.com | USD 482m | 4.7% |
| 2 | Whitebox Advisors9 funds on PPLI.com | USD 148m | 1.9% |
| 3 | Maverick Capital20 funds on PPLI.com | USD 108m | 1.0% |
| 4 | Millennium Management6 funds on PPLI.com | USD 70m | 0.0% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 68m | 0.0% |
| 6 | Tudor Investment Corporation10 funds on PPLI.com | USD 67m | 0.1% |
| 7 | TIG Advisors15 funds on PPLI.com | USD 60m | 2.6% |
| 8 | Balyasny Asset Management25 funds on PPLI.com | USD 59m | 0.1% |
| 9 | Magnetar Financial93 funds on PPLI.com | USD 54m | 0.5% |
| 10 | Alpine Associates Management9 funds on PPLI.com | USD 35m | 2.2% |
| 11 | Durable Capital Partners2 funds on PPLI.com | USD 35m | 0.3% |
| 12 | Pentwater Capital Management1 fund on PPLI.com | USD 35m | 0.2% |
| 13 | Verition Fund Management3 funds on PPLI.com | USD 31m | 0.2% |
| 14 | Adage Capital Management1 fund on PPLI.com | USD 28m | 0.0% |
| 15 | Sculptor Capital67 funds on PPLI.com | USD 25m | 0.2% |
| 16 | Water Island Capital1 fund on PPLI.com | USD 24m | 2.2% |
| 17 | D. E. Shaw & Co.15 funds on PPLI.com | USD 16m | 0.0% |
| 18 | Capstone Investment Advisors25 funds on PPLI.com | USD 15m | 0.0% |
| 19 | Slotnik Capital1 fund on PPLI.com | USD 15m | 3.8% |
| 20 | Hudson Bay Capital Management8 funds on PPLI.com | USD 14m | 0.0% |
| 21 | Gabelli & Company Investment Advisers17 funds on PPLI.com | USD 11m | 1.7% |
| 22 | Moore Capital Management7 funds on PPLI.com | USD 8.9m | 0.1% |
| 23 | Ananym Capital Management2 funds on PPLI.com | USD 8.5m | 3.0% |
| 24 | Prelude Capital Management9 funds on PPLI.com | USD 6.5m | 0.5% |
| 25 | Squarepoint Ops7 funds on PPLI.com | USD 6.4m | 0.0% |
| 26 | Marshall Wace LLP84 funds on PPLI.com | USD 6.3m | 0.0% |
| 27 | Cinctive Capital Management5 funds on PPLI.com | USD 5.5m | 0.2% |
| 28 | Boothbay Fund Management2 funds on PPLI.com | USD 5.2m | 0.1% |
| 29 | Two Sigma Investments35 funds on PPLI.com | USD 4.9m | 0.0% |
| 30 | Alpine Peaks Capital4 funds on PPLI.com | USD 4.7m | 5.5% |
| 31 | P. Schoenfeld Asset Management1 fund on PPLI.com | USD 4.6m | 1.9% |
| 32 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 4.1m | 0.0% |
| 33 | Glenview Capital Management9 funds on PPLI.com | USD 4.1m | 0.1% |
| 34 | Sciencast Management1 fund on PPLI.com | USD 4m | 0.8% |
| 35 | Versor Investments8 funds on PPLI.com | USD 3m | 6.3% |
| 36 | LMR Partners2 funds on PPLI.com | USD 2.5m | 0.0% |
| 37 | CIBC Asset Management69 funds on PPLI.com | USD 2.4m | 0.0% |
| 38 | Engineers Gate Manager1 fund on PPLI.com | USD 2.1m | 0.0% |
| 39 | Bridgewater Associates45 funds on PPLI.com | USD 1.9m | 0.0% |
| 40 | Exoduspoint Capital Management7 funds on PPLI.com | USD 1.9m | 0.0% |
| 41 | Landscape Capital Management4 funds on PPLI.com | USD 1.8m | 0.1% |
| 42 | Kintayl Capital2 funds on PPLI.com | USD 1.6m | 0.6% |
| 43 | Eversept Partners3 funds on PPLI.com | USD 1.4m | 0.1% |
| 44 | Neo Ivy Capital Management1 fund on PPLI.com | USD 799,000 | 0.2% |
| 45 | Wolverine Asset Management1 fund on PPLI.com | USD 740,000 | 0.0% |
| 46 | Caxton Associates6 funds on PPLI.com | USD 727,000 | 0.0% |
| 47 | Gamco Asset Management1 fund on PPLI.com | USD 442,000 | 0.0% |
| 48 | The Quarry1 fund on PPLI.com | USD 335,000 | 0.0% |
| 49 | Hyperion Capital Advisors2 funds on PPLI.com | USD 283,000 | 0.1% |
| 50 | Trust Asset Management4 funds on PPLI.com | USD 217,000 | 0.0% |
| 51 | Walleye Capital8 funds on PPLI.com | USD 170,000 | 0.0% |
| 52 | Bayforest Capital1 fund on PPLI.com | USD 3,815 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Versor Investments | USD 3m | 6.3% |
| 2 | Alpine Peaks Capital | USD 4.7m | 5.5% |
| 3 | HBK Investments | USD 482m | 4.7% |
| 4 | Slotnik Capital | USD 15m | 3.8% |
| 5 | Ananym Capital Management | USD 8.5m | 3.0% |
| 6 | TIG Advisors | USD 60m | 2.6% |
| 7 | Alpine Associates Management | USD 35m | 2.2% |
| 8 | Water Island Capital | USD 24m | 2.2% |
| 9 | Whitebox Advisors | USD 148m | 1.9% |
| 10 | P. Schoenfeld Asset Management | USD 4.6m | 1.9% |
BIO-TECHNE Corp trades under the symbol TECH on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09073M104.
52 of the 720 hedge fund managers PPLI.com tracks reported BIO-TECHNE Corp shares on Form 13F for 30 June 2026. The largest reported positions were held by HBK Investments (USD 482m), Whitebox Advisors (USD 148m), Maverick Capital (USD 108m), Millennium Management (USD 70m) and Citadel Advisors (USD 68m).
52 managers in our coverage reported it, and between them they run 729 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Versor Investments, where the position was 6.3% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BIO-TECHNE Corp or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.